SFTPD and type 2 diabetes mellitus: Moreover, serum SP-D in this population was independently and inversely associated with FEV1 in the obese diabetes patients and the authors concluded serum SP-D might be a useful biomarker for detecting lung impairment in obese patients with type 2 diabetes.